Aspen Aerogels Reports Q2 2025 Revenue of $78M, Net Loss of $9.1M, and CFO Transition

ASPEN AEROGELS INC

2025-Q2 EPS reported -$3.78 revenue$156,747,000

Total revenue for Q2 2025 was $78.0 million, down from $117.8 million in Q2 2024.
Net loss was $9.1 million, including $5.9 million of restructuring and impairment charges, compared to net income of $16.8 million a year ago.
Adjusted EBITDA for Q2 2025 was $9.7 million, versus $28.9 million in the prior-year quarter.
Aspen announces a CFO transition to an internal successor during Q3 2025.
Fixed cost structure reductions are expected to drive incremental profit in the second half of 2025.

item 2.02item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.